FED PANEL SAYS VALUE OF WORKPLACE DRUG TESTING UNPROVEN

Forensic Drug Abuse Advisor Vo. 7 (1) January 1995, p.6

Subcommittees of the National Research Council and the Institute of
Medicine have completed a study assessing the extent of drug use in the
workplace, and the impact of drug abuse on job performance. Drug testers
may be a little upset by some of its conclusions, since the study raises
important questions about the scientific rationale for workplace drug
testing.

Workplace drug testing is a very big business. The study group estimates
that the United States is spending at least 1.2 billion dollars per year on
drug testing (24 million tests per year at an estimated total cost of $50
each), not counting any money spent on time lost from work attributable to
the testing process. Statistical evidence from a variety of sources
suggest that, except for alcohol, drug use in the workplace has been
steadily decreasing for the last 15 years (the percentage of heavy
drinkers in the population appears to be unchanged). In 1990, the overall
rate for workers admitting to having used an illicit drug some time during
the preceding month was 7%. However, today in some areas, such as the air
transport and nuclear industry, the rate is well below 1%.

No study has ever demonstrated that this decrease is due to the work
testing program, nor has it been demonstrated with any certainty that, in
commonly used doses, any of the widely abused drugs significantly impacts
on job performance. There is, however, good evidence that drug users are
more likely to be absent from work, and there is also good evidence that
alcohol abuse is associated with increased occupational injuries.

The committee felt that much of the data reviewed for its report was
flawed, or at least of dubious statistical power, and they concluded that
"the preventive effects of drug-testing programs have never been adequately
demonstrated." As Craig Zwerling pointed out in a recent issue of JAMA,
Journal of the American Medical Association (272 [18] 1467-1468), the
conclusion reached by the study group was the same as that reached in a
1992 study, namely that there was "almost no credible warrant of
effectiveness."

Zwerling also went on to note that "a large industry of drug testers has
arisen with a financial stake in expanding the market for workplace drug
tests. The industry includes the companies that manufacture the equipment
and chemicals used in drug testing, the laboratories that carry out the
test, the companies that collect the urine specimens, the medical review
officers (MRO's) who review the test results, and the consultants who
advise companies on drug testing."

The study was sponsored by NIDA (National Institute on Drug Abuse) and the
results have been published in book form by the National Academy Press.
The full title is "Under the Influence? Drugs and the American Work
Force," Normand, J, Lempert, R, and O'Brien, C eds. (Committee on Drug
Use in the Workplace, National Research Council / Institute of Medicine).
321 pp $39.95, ISBN 0-309-04885-0

COMMENT: This book should be required reading. Somebody has to do the
studies to prove that the whole process works. But who is going to put up
the money to do the studies? NIDA has just as big a vested interest in
maintaining the status quo as the drug testing companies, and the reagent
manufacturers. In fact, it may be too late to ever do the studies that
would justify the money and effort being spent on these programs.


INDEX

HOME